EARNEST PARTNERS LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-09 5:09 pm Sale | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 3,304,456 4.100% | -3,011,909 (-47.68%) | Filing |
| 2022-02-10 5:37 pm Sale | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 6,316,365 7.900% | -415,064 (-6.17%) | Filing |
| 2021-02-16 3:33 pm Purchase | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 6,731,429 9.000% | 6,731,429 (New Position) | Filing |